OBJECTIVE:Insulin-like growth factors (IGF) are increasingly recognized as important determinants of adult health, in particular risk of certain cancers. However, little is known about the determinants of adult IGFs and to what degree they may be programmed by early life influences. DESIGN: Randomized controlled trial of prenatal and postnatal milk supplementation among 951 subjects born in 1972 to 1974 in South Wales. MAIN OUTCOME MEASURE: Measures of IGF-I, IGF binding protein 3, and the molar ratio. RESULTS: Data on adult IGFs were available from 663 subjects at a mean age of 25 years. Subjects in the intervention arm had lower IGF-I (-8.5 ng/mL; 95% confidence interval, -15.1 to -1.8, P = 0.01) and ratio (-1.20; 95% confidence interval, -2.33 to -0.04, P = 0.04). These differences could not be explained by follow-up bias or confounding factors. CONCLUSIONS: These results provide experimental data on the role of early life programming either in the intrauterine or postnatal period that may have long-term influences on the IGF axis, with potential implications for disease risk.
RCT Entities:
OBJECTIVE: Insulin-like growth factors (IGF) are increasingly recognized as important determinants of adult health, in particular risk of certain cancers. However, little is known about the determinants of adult IGFs and to what degree they may be programmed by early life influences. DESIGN: Randomized controlled trial of prenatal and postnatal milk supplementation among 951 subjects born in 1972 to 1974 in South Wales. MAIN OUTCOME MEASURE: Measures of IGF-I, IGF binding protein 3, and the molar ratio. RESULTS: Data on adult IGFs were available from 663 subjects at a mean age of 25 years. Subjects in the intervention arm had lower IGF-I (-8.5 ng/mL; 95% confidence interval, -15.1 to -1.8, P = 0.01) and ratio (-1.20; 95% confidence interval, -2.33 to -0.04, P = 0.04). These differences could not be explained by follow-up bias or confounding factors. CONCLUSIONS: These results provide experimental data on the role of early life programming either in the intrauterine or postnatal period that may have long-term influences on the IGF axis, with potential implications for disease risk.
Authors: Tina S Nielsen; Galam Khan; Jennifer Davis; Karin B Michels; Leena Hilakivi-Clarke Journal: Int J Cancer Date: 2011-01-01 Impact factor: 7.396
Authors: Luisa Zuccolo; Ross Harris; David Gunnell; Steven Oliver; Jane Athene Lane; Michael Davis; Jenny Donovan; David Neal; Freddie Hamdy; Rebecca Beynon; Jelena Savovic; Richard Michael Martin Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-09 Impact factor: 4.254
Authors: John Macleod; Lie Tang; F D Richard Hobbs; Brian Wharton; Roger Holder; Shakir Hussain; Linda Nichols; Paul Stewart; Penny Clark; Steve Luzio; Jeff Holly; George Davey Smith Journal: PLoS One Date: 2013-12-13 Impact factor: 3.240
Authors: David Bann; Jeff M P Holly; Hany Lashen; Rebecca Hardy; Judith Adams; Diana Kuh; Ken K Ong; Yoav Ben-Shlomo Journal: Obesity (Silver Spring) Date: 2015-02-03 Impact factor: 5.002
Authors: David Bann; Rebecca Hardy; Rachel Cooper; Hany Lashen; Brian Keevil; Frederick C W Wu; Jeff M P Holly; Ken K Ong; Yoav Ben-Shlomo; Diana Kuh Journal: Soc Sci Med Date: 2015-11-06 Impact factor: 4.634